Eli Lilly and Company: Bipolar Disorder trials
The registry lists 20 Bipolar Disorder studies with Eli Lilly and Company as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 1 2Phase 2 1Phase 3 5Phase 4 11No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)RecruitingNCT07286175Phase 2
- A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar DepressionCompletedNCT00844857Phase 4Results posted
- Olanzapine Treatment of Patients With Bipolar I DisorderCompletedNCT00510146Phase 3Results posted
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
- Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineCompletedNCT00259272Phase 3Results posted
- Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderCompletedNCT00129220Phase 3Results posted
- A Study of LY2979165 in Healthy SubjectsCompletedNCT01383967Phase 1
- A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy VolunteersCompletedNCT01248052Phase 1
- A Study in the Treatment of Acute ManiaTerminatedNCT00767715Phase 4
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.CompletedNCT00510211
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCompletedNCT00485771Phase 4
- Olanzapine Versus Comparator in the Treatment of Bipolar DisorderCompletedNCT00485680Phase 3
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
- Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment ResponseCompletedNCT00191399Phase 4
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNCT00050206Phase 4
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCompletedNCT00044187Phase 4
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I DisorderCompletedNCT00034580Phase 4